University of Bristol at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University of Bristol brings 2 presentations to ESGCT 2026 in Hamburg. Its program covers kidney disease gene therapy and blood stem cell gene therapy. It includes where kidney gene therapy technology stands today and blood stem cells from the patient used to treat Friedreich's ataxia.
| Organization | ESGCT 2026 Attendance |
|---|---|
University of Bristol Bristol, UK | |
UK research university with groups developing gene therapy for kidney disease. | Talk Wed Oct 28 9:00am–10:30am Gene therapy for kidney disease, current technology and future perspectives Vectors and delivery (AAV, lentiviral, LNP) Talk Thu Oct 29 5:45pm–6:00pm Autologous haematopoietic stem cell gene therapy for people with Friedreich’s Ataxia Rare and inherited diseaseVectors and delivery (AAV, lentiviral, LNP) |
Instantly find 20 buyers from University of Bristol
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction